Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors
- 1 April 1990
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 179 (3), 339-345
- https://doi.org/10.1016/0014-2999(90)90174-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Type I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected CellsScience, 1989
- Enhancement of GABAergic transmission by zolpidem, an imidazopyridine with preferential affinity for type I benzodiazepine receptorsEuropean Journal of Pharmacology, 1989
- Antagonism of ethanol effects by Ro 15‐4513: An electrophysiological analysisSynapse, 1989
- Structural and functional basis for GABAA receptor heterogeneityNature, 1988
- Clinical studies with the new anxiolytic alpidem in anxious patients: An overview of the European experiencesPharmacology Biochemistry and Behavior, 1988
- Molecular biology of the GABAA receptor: the receptor/channel superfamilyTrends in Neurosciences, 1987
- The β-carboline ZK 93423 inhibits reticulata neurons: An effect reversed by benzodiazepine antagonistsLife Sciences, 1987
- High affinity [3H]zolpidem binding in the rat brain: an imidazopyridine with agonist properties at central benzodiazepine receptorsEuropean Journal of Pharmacology, 1986
- Evidence for the presence of benzodiazepine receptor subclasses in different areas of the human brainNeuroscience Letters, 1984
- β-carbolines activate neurons in the substantia nigra pars reticulata: An effect reversed by diazepam and Ro15-1788European Journal of Pharmacology, 1983